m+Medelevator.RU
← Поиск публикаций
Naunyn-Schmiedeberg's archives of pharmacology · 2026

Unraveling potent therapeutic potentials of tanshinones, lipophilic abietane diterpenes: a holistic literature review.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Abdel-Dayem Shymaa I A, Kamal Rania M, Ghaiad Heba R, Ahmed Mariam K, Eid Aya H, El-Dessouki Ahmed M, Elazazy Ola, El-Tokhy Fatma Saeed, Fahim Sally A, El-Shiekh Riham A, Elghany Eman M Abd

Аннотация

Tanshinones, a class of lipophilic abietane-type diterpenoid, represents the major bioactive constituents of Salvia miltiorrhiza Bunge (Danshen), a key herb in traditional Chinese medicine with growing therapeutic importance. This review offers an in-depth overview of tanshinones from phytochemical and pharmacological perspectives. The review outlines the biosynthetic pathway, highlights the key synthetic approaches, and provides a detailed chemical and stereochemical characterization of the major tanshinones isomers. Pharmacologically, tanshinones exhibit broad, multi-system activities including antioxidant and anti-inflammatory effects, cardiovascular and hepatorenal protection, antitumor activity, immunomodulatory effects, and therapeutic benefits across neurological, metabolic, skeletal, respiratory, and infectious diseases. Despite their broad therapeutic potential, progression of tanshinones toward clinical application is restricted by low oral bioavailability, poor aqueous solubility, and rapid metabolism. To overcome these barriers, novel drug-delivery strategies including lipid nanocapsules, liposomes, polymeric nanoparticles, solid liquid nanoparticles, microemulsions, and nanoemulsions significantly improve solubility, stability, and pharmacokinetics. This review integrates the current evidence to guide future optimization and mechanistic exploration and support the development of innovative nanoformulations for next-generation tanshinone-based therapies.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты